Applied DNA Sciences Files Proxy Statement for May 22 Meeting
Ticker: BNBX · Form: DEF 14A · Filed: Apr 15, 2025 · CIK: 744452
| Field | Detail |
|---|---|
| Company | Applied Dna Sciences INC (BNBX) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: APDN
TL;DR
APDN proxy filed, shareholder vote on May 22. Expect votes on exec pay & board.
AI Summary
Applied DNA Sciences Inc. filed its definitive proxy statement on April 15, 2025, for its annual meeting on May 22, 2025. The company, previously known as ProHealth Medical Technologies Inc., is seeking shareholder approval for various corporate matters. The filing details executive compensation, board nominations, and other proposals to be voted on by shareholders.
Why It Matters
This filing is crucial for shareholders as it outlines the company's governance, executive compensation, and key proposals that will shape its future direction and financial performance.
Risk Assessment
Risk Level: medium — Proxy statements can reveal important information about a company's financial health, governance, and future plans, which can significantly impact its stock price.
Key Numbers
- 0930 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
- 001-36745 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- APPLIED DNA SCIENCES INC (company) — Filer of the proxy statement
- 0001104659-25-034898 (dollar_amount) — Accession number for the filing
- 20250415 (dollar_amount) — Filing date
- 20250522 (dollar_amount) — Conformed period of report / meeting date
- PROHEALTH MEDICAL TECHNOLOGIES INC (company) — Former company name
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting of stockholders, including proposals to be voted on, director nominations, and executive compensation.
When is the scheduled date for the annual meeting of stockholders?
The conformed period of report is May 22, 2025, which is the date of the annual meeting of stockholders.
What was Applied DNA Sciences Inc. previously known as?
Applied DNA Sciences Inc. was previously known as PROHEALTH MEDICAL TECHNOLOGIES INC.
What is the company's fiscal year end?
The company's fiscal year ends on September 30 (0930).
What is the SEC file number for Applied DNA Sciences Inc.?
The SEC file number for Applied DNA Sciences Inc. is 001-36745.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 15, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).